Dr. Peter Rehse has been named senior director, Structural Biology at BioFocus. He will be based at Chesterford Park, near Cambridge, UK. His responsibilities will include managing the structural biology and fragment-based screening groups within the Biological Sciences division.
Dr. Rehse has joined the company from the Chinese CRO Shanghai Medicilon Inc., where, as vice president, he was responsible for the strategic business and scientific development of the structural biology and structure-based drug design unit. Prior to this, he worked at RIKEN Harima Institute in Japan and has held several academic positions in Japan and Canada.
“With Peter’s international credibility we will be able to strengthen and grow our structural biology and fragment screening operation,” commented Dr. Kate Hilyard, vice president Biological Sciences, BioFocus. “This hire reflects our ongoing commitment to accelerate our client’s discovery programs through investing in the right people."